Different approaches to bone densitometry

Journal of Nuclear Medicine

Volumn 41, Issue 12, 2000, Pages 2015-2025

  Fogelman, I ^a   Blake, G M ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Bone densitometry; Dual energy x ray absorptiometry; Osteoporosis; Quantitative CT; Quantitative ultrasound; Radiographic absorptiometry

Indexed keywords

BONE DENSITY; COMPUTER ASSISTED TOMOGRAPHY; DENSITOMETRY; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FRACTURE; HIP SCINTISCANNING; HUMAN; OSTEOPOROSIS; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; REVIEW; SPINE SCINTISCANNING;

BONE DENSITY; BONE DISEASES, METABOLIC; DENSITOMETRY, X-RAY; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034518397     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Guidelines for diagnosis and treatment of osteoporosis
2. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation
3. Costs and health effects of osteoporotic fractures
4. Race and sex differences in mortality following fracture of the hip
5. Ambulatory ability after hip fracture: A prospective study in geriatric patients
6. 3 and calcium to prevent fractures in elderly women
7. Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures
8. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial
9. Hormone therapy to prevent disease and prolong life in postmenopausal women
10. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
11. Bisphosphonates: A review of their pharmacokinetic properties
12. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
13. Risedronate increases bone mass in an early postmenopausal population: Two years of treatment plus one year of follow-up
14. Effects of raloxifine on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
15. Treatment of established postmenopausal osteoporosis with raloxifene: A randomized trial
16. Noninvasive assessment of bone mineral and structure: State of the art
17. Comparisons of non-invasive bone mineral measurements in assessing age-related loss, fracture discrimination and diagnostic classification
18. Technical principles of dual energy x-ray absorptiometry
19. Diagnosis, prophylaxis and treatment of osteoporosis
20. The diagnosis of osteoporosis
21. Interpretation of bone densitometry studies
22. Assessment of fracture risk by bone density measurements
23. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures
24. Bone density at various sites for prediction of hip fractures
25. Treatment of postmenopausal osteoporosis
26. Radiation exposure in bone mineral assessment
27. Errors due to non-uniform distribution of fat in dual x-ray absorptiometry of the lumbar spine
28. Impact of soft tissue on in-vivo accuracy of bone mineral measurements in the spine, hip, and forearm: A human cadaver study
29. Occupational dose to the radiographer in dual x-ray absorptiometry: A comparison of pencil-beam and fan-beam systems
30. Quantitative CT for determination of bone mineral density: A review
31. Effective dose values in bone mineral measurements by photon absorptiometry and computed tomography
32. Peripheral measurement techniques for the assessment of osteoporosis
33. Measurement of bone mineral in vivo: An improved method
34. A single bone density measurement can predict fractures over 25 years
35. Radiation dose to the patient and operator from a peripheral dual x-ray absorptiometry system
36. Bone densitometry: Choosing the proper skeletal site to measure
37. Prevention of bone loss in postmenopausal women under 60 years of age. Early postmenopausal intervention cohort study group
38. The role of ultrasound in the assessment of osteoporosis: A review
39. Influence of temperature on ultrasonic properties of the calcaneus in situ
40. Ultrasonographic heel measurements to predict hip fracture in elderly women: The EPIDOS prospective study
41. Broadband ultrasonic attenuation predicts fractures strongly and independently of densitometry in older women
42. Ultrasound measurements for the prediction of osteoporotic fractures in elderly people
43. Discordance in patient classification using T-scores
44. Do we need to change the WHO definition of osteoporosis?
45. An update on the diagnosis and assessment of osteoporosis with densitometry
46. Quantitative ultrasound imaging at the calcaneus using an automatic region of interest
47. Quantitative ultrasound techniques for the assessment of osteoporosis - Expert agreement on current status
48. Discrepancies in normative data between Lunar and Hologic DXA systems
49. Standardization of femur BMD
50. Updated data on proximal femur bone mineral levels of US adults
51. How the new Hologic hip reference values affect the densitometric diagnosis of osteoporosis
52. Universal standardization for dual x-ray absorptiometry: Patient and phantom cross-calibration results
53. Standardization of spine BMD measurements
54. Osteoporosis: Review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis
55. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fracture: Results from the Fracture Intervention Trial